Precision Biosciences (NASDAQ: DTIL) revenue
Precision Biosciences reported revenue of $34.3m for fiscal 2025, 50.1% less than in fiscal 2024 ($68.7m). Since fiscal 2018 its revenue has grown by 214.8%, an average growth of 17.8% a year.
Precision Biosciences's best year of the last 8 was fiscal 2021. The biggest drop was in fiscal 2022, −78.3%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $34.3m | −50.1% | −$52.1m | −152.2% |
| 2024 | $68.7m | +41.0% | −$26.2m | −38.1% |
| 2023 | $48.7m | +94.1% | −$43.7m | −89.8% |
| 2022 | $25.1m | −78.3% | −$62.3m | −248.3% |
| 2021 | $115.5m | +375.7% | −$39.4m | −34.1% |
| 2020 | $24.3m | +9.2% | −$109.8m | −452.2% |
| 2019 | $22.2m | +104.3% | −$87.2m | −392.1% |
| 2018 | $10.9m | — | −$47.9m | −440.2% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Precision Biosciences revenue compared with its sector
By revenue for its latest fiscal year, Precision Biosciences ranks 346th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Precision Biosciences, −50.1%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 344th | Senseonics | $35.3m | 56.9% |
| 345th | X4 Pharmaceuticals | $35.1m | 1,250.5% |
| 346th | Precision Biosciences | $34.3m | −50.1% |
| 347th | Orchestra BioMed | $33.5m | 1,169.2% |
| 348th | Stereotaxis | $32.4m | 20.3% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Precision Biosciences
- How much revenue did Precision Biosciences make in fiscal 2025?
- Precision Biosciences reported revenue of $34.3m for fiscal 2025, compared with $68.7m in fiscal 2024.
- How much has the revenue of Precision Biosciences grown?
- Between fiscal 2018 and fiscal 2025 it went from $10.9m to $34.3m: 214.8% more, an average growth of 17.8% a year.
- What was the best year for revenue at Precision Biosciences?
- Of its last 8 fiscal years, fiscal 2021, with $115.5m.
- Where does Precision Biosciences rank in its sector by revenue?
- It ranks 346th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Precision Biosciences come from?
- From the annual report (Form 10-K) that Precision Biosciences files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Precision Biosciences files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018. More on Precision Biosciences: the Precision Biosciences page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.